Background: This study investigated in vivo regulation and levels of active matrix metalloproteinase-8 (aMMP-8), a major collagenolytic protease, in periodontitis. Methods: Twenty-seven adults with chronic periodontitis (CP) and 30 periodontally healthy controls (HC) were enrolled in immunohistochemistry and transcriptomics analytics in order to assess Treponema denticola (Td) dentilisin and MMP-8 immunoexpression, mRNA expression of MMP-8 and its regulators (IL-1β, MMP-2, MMP-7, TIMP-1). Furthermore, the periodontal anti-infective treatment effect was monitored by four different MMP-8 assays (aMMP-8-IFMA, aMMP-8-Oralyzer, MMP-8-activity [RFU/minute], and total MMP-8 by ELISA) among 12 CP (compared to 25 HC). Results: Immunohistochemistry revealed significantly more Td-dentilisin and MMP-8 immunoreactivities in CP vs. HC. Transcriptomics revealed significantly elevated IL-1β and MMP-7 RNA expressions, and MMP-2 RNA was slightly reduced. No significant differences were recorded in the relatively low or barely detectable levels of MMP-8 mRNAs. Periodontal treatment significantly decreased all MMP-8 assay levels accompanied by the assessed clinical indices (periodontal probing depths, bleeding-on-probing, and visual plaque levels). However, active but not total MMP-8 levels persisted higher in CP than in periodontally healthy controls. Conclusion: In periodontal health, there are low aMMP-8 levels. The presence of Td-dentilisin in CP gingivae is associated with elevated aMMP-8 levels, potentially contributing to a higher risk of active periodontal tissue collagenolysis and progression of periodontitis. This can be detected by aMMP-8-specific assays and online/real-time aMMP-8 chair-side testing.
According to the data of Global Burden Disease in 2016, periodontal disease is the 11th disease suffered by 750,487 people worldwide. Gingivitis occurs due to dental plaque formation. A half of bacterial plaque populations are Streptococcus sp. Streptococcus sanguinis is a predominant bacterial that initiates plaque formation. The adherence of this bacteria is mediated by fimbriae, pilus protein, lipoprotein, and glucosyltransferase enzymes. Hibiscus flower has a potential as an antimicrobial agent that may inhibit plaque formation due its active component i.e. flavonoid, tannins, and saponin. This study aimed to investigate the effect of Hibiscus rosa-sinensis L. flower extract concentration on the growth of Streptococcus sanguinis. Wells diffusion method was used in this study, using 100 μl bacterial suspension of 1,5 x 108 CFU/ml of bacteria. Hibiscus flower extract (2%, 4%, 6%), chlorhexidine 0,12% as a positive control, and distilled water as a negative control were added in the agar wells. The results showed that all concentrations (2 %, 4%, 6 %) of Hibiscus flower extract higher significantly compared to negative control. The concentration of 4% and 6% are higher ;significantly compared to positive control. The largest inhibitory zone was at a concentration of 6% (6,35±0,09 mm) and the smallest inhibitory zone was at a concentration of 2% (2,51±0,12 mm). The conclusion is that the concentration of Hibiscus rosa-sinensis L. flower extract affects the growth of Streptococcus sanguinis.
Objectives: To investigate whether Porphyromonas gingivalis gingipains contribute to the activation of MMP-8 and MMP-9 in patients with cancer and to evaluate the potential of aMMP-8 chair-side test for early detection of active periodontal inflammation in cancer care. Methods: This cross-sectional study enrolled 89 of 119 initially assessed patients with cancer at Dr. Sardjito Hospital, Yogyakarta, Indonesia (2023–2024). Active MMP-8 was quantified using a chair-side test on oral rinse samples. Total MMP-8 was measured by ELISA, MMP-9 activation by gelatin zymography, and gingipain presence by Western immunoblotting. Associations with periodontal parameters (PPD, GI, OHI-S, and VPI) were analyzed using linear regression. Results: aMMP-8 chair-side test demonstrated 91% positive results in 89 patients with cancer. Western blotting revealed the co-localization of gingipains with fragmented MMP-8. aMMP-8 levels were significantly associated with MMP-9 activation (p = 0.003, R2 = 0.097), suggesting proteolytic cascade activation. Oral hygiene indices showed stronger associations (OHI-S: p = 0.003, R2 = 0.100; VPI: p = 0.014, R2 = 0.067) than deeper periodontal parameters (PPD: p = 0.094; GI: p = 0.358), suggesting early-stage inflammation detection. Conclusions: Gingipain presence may be associated with the activation of MMP-8 and MMP-9 in patients with cancer, which links bacterial virulence to amplified tissue destruction. aMMP-8 chair-side test enables rapid identification of active inflammation, facilitating timely periodontal intervention during cancer care.
30 December 2022 in MKGK (Majalah Kedokteran Gigi Klinik) (Clinical Dental Journal) UGM
Karbonat hidroksiapatit (carbonated hydroxyapatite, CHA) memiliki osteokonduktivitas yang lebih baik daripada hidroksiapatit (HA). Secara in vivo, CHA lebih mudah larut daripada HA serta dapat meningkatkan konsentrasi lokal ion kalsium dan fosfat yang diperlukan untuk proses pembentukan jaringan tulang baru. Tes biokompatibilitas jaringan lunak diperlukan untuk setiap bahan implan karena ketika diaplikasikan ke dalam tubuh yang akan kontak dengan jaringan lunak. Penelitian ini bertujuan untuk mengevaluasi biokompatibiltas CHA dan HA di jaringan lunak. CHA dan HA ditanamkan pada jaringan subkutan paravertebral dari 12 tikus Wistar jantan. Irisan histologis diwarnai dengan Hematoksilin Eosin. Kuantitas dan kualitas kapsul fibrosa serta jumlah sel raksasa benda asing (foreign body giant cells, FBGCs) dan nukleinya dievaluasi. Perbedaan modus kualitas dan kuantitas kapsul antara periode implantasi dianalisis dengan Kruskall-Wallis, sedangkan perbedaan modus antara bahan implan pada periode yang sama dianalisis dengan uji Wilcoxon. Rata-rata FBGCs dinilai dengan two-way ANOVA dengan interval kepercayaan 95% diikuti dengan uji-t berpasangan untuk menganalisis perbedaan rata-rata antara bahan dan uji-t sampel independen untuk menganalisis perbedaan rata-rata antara periode implantasi. Hasil penelitian menunjukkan tidak ada perbedaan yang signifikan dalam kuantitas dan kualitas kapsul setelah implantasi CHA dan HA pada periode yang sama dan antar periode (p ≥ 0,05). Jumlah FBGCs di CHA setelah 14, 21, 28 hari implantasi secara signifikan lebih rendah dibandingkan dengan HA, akan tetapi tidak ada perbedaan yang signifikan dalam jumlah nuklei FBGC antara implantasi HA dan CHA. Kesimpulan studi ini menunjukkan bahwa CHA lebih biokompatibel daripada HA, terutama pada fase subkronik.